Literature DB >> 25498860

Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome.

Jeanelle Ariza1, Craig Steward2, Flora Rueckert2, Matt Widdison2, Robert Coffman2, Atiyeh Afjei2, Stephen C Noctor3, Randi Hagerman4, Paul Hagerman5, Verónica Martínez-Cerdeño6.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene that is characterized by progressive action tremor, gait ataxia, and cognitive decline. Recent studies of mitochondrial dysfunction in FXTAS have suggested that iron dysregulation may be one component of disease pathogenesis. We tested the hypothesis that iron dysregulation is part of the pathogenic process in FXTAS. We analyzed postmortem choroid plexus from FXTAS and control subjects, and found that in FXTAS iron accumulated in the stroma, transferrin levels were decreased in the epithelial cells, and transferrin receptor 1 distribution was shifted from the basolateral membrane (control) to a predominantly intracellular location (FXTAS). In addition, ferroportin and ceruloplasmin were markedly decreased within the epithelial cells. These alterations have implications not only for understanding the pathophysiology of FXTAS, but also for the development of new clinical treatments that may incorporate selective iron chelation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism; CGG repeat; Choroid plexus; FMR1; FXTAS; Fragile X; Iron; Neurodegeneration; Premutation

Mesh:

Substances:

Year:  2014        PMID: 25498860      PMCID: PMC4340768          DOI: 10.1016/j.brainres.2014.11.058

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  50 in total

Review 1.  The choroid plexus in the rise, fall and repair of the brain.

Authors:  Dwaine F Emerich; Stephen J M Skinner; Cesario V Borlongan; Alfred V Vasconcellos; Chistopher G Thanos
Journal:  Bioessays       Date:  2005-03       Impact factor: 4.345

2.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

3.  Psammoma bodies - friends or foes of the aging choroid plexus.

Authors:  Ivan Jovanović; Sladjana Ugrenović; Ljiljana Vasović; Dragan Petrović; Sonja Cekić
Journal:  Med Hypotheses       Date:  2010-02-08       Impact factor: 1.538

Review 4.  Aceruloplasminemia.

Authors:  Satoshi Kono
Journal:  Curr Drug Targets       Date:  2012-08       Impact factor: 3.465

5.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

6.  Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation.

Authors:  Carin Thomas; Melissa M Mackey; Amy A Diaz; David P Cox
Journal:  Redox Rep       Date:  2009       Impact factor: 4.412

7.  Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study.

Authors:  Cary S Kogan; Jeremy Turk; Randi J Hagerman; Kim M Cornish
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

8.  Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis.

Authors:  Claudia M Greco; Flora Tassone; Dolores Garcia-Arocena; Nicole Tartaglia; Sarah M Coffey; Timothy K Vartanian; James A Brunberg; Paul J Hagerman; Randi J Hagerman
Journal:  Arch Neurol       Date:  2008-08

Review 9.  Transferrin-mediated cellular iron delivery.

Authors:  Ashley N Luck; Anne B Mason
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

Review 10.  Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Authors:  Randi J Hagerman; Deborah A Hall; Sarah Coffey; Maureen Leehey; James Bourgeois; John Gould; Lin Zhang; Andreea Seritan; Elizabeth Berry-Kravis; John Olichney; Joshua W Miller; Amy L Fong; Randall Carpenter; Cathy Bodine; Louise W Gane; Edgar Rainin; Hillary Hagerman; Paul J Hagerman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  21 in total

Review 1.  Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Authors:  Reymundo Lozano; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 2.  General Anesthetic Use in Fragile X Spectrum Disorders.

Authors:  Andrew Ligsay; Marwa El-Deeb; Maria J Salcedo-Arellano; Nina Schloemerkemper; Jeremy S Grayson; Randi Hagerman
Journal:  J Neurosurg Anesthesiol       Date:  2019-07       Impact factor: 3.956

3.  Microglial cell activation and senescence are characteristic of the pathology FXTAS.

Authors:  Verónica Martínez Cerdeño; Tiffany Hong; Sarwat Amina; Mirna Lechpammer; Jeanelle Ariza; Flora Tassone; Stephen C Noctor; Paul Hagerman; Randi Hagerman
Journal:  Mov Disord       Date:  2018-12-10       Impact factor: 10.338

Review 4.  [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

Authors:  M J Salcedo-Arellano; R J Hagerman; V Martinez-Cerdeno
Journal:  Rev Neurol       Date:  2019-03-01       Impact factor: 0.870

5.  Emerging Role of the Cerebrospinal Fluid - Neuronal Interface in Neuropathology.

Authors:  Vanessa Ochoa; Annalee J Loeffler; Christie D Fowler
Journal:  Neuro       Date:  2015-10-13

6.  Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene.

Authors:  Veronica Nobile; Federica Palumbo; Stella Lanni; Valentina Ghisio; Alberto Vitali; Massimo Castagnola; Valeria Marzano; Giuseppe Maulucci; Claudio De Angelis; Marco De Spirito; Laura Pacini; Laura D'Andrea; Rino Ragno; Giulia Stazi; Sergio Valente; Antonello Mai; Pietro Chiurazzi; Maurizio Genuardi; Giovanni Neri; Elisabetta Tabolacci
Journal:  Hum Genet       Date:  2020-01-09       Impact factor: 4.132

7.  Iron accumulation and dysregulation in the putamen in fragile X-associated tremor/ataxia syndrome.

Authors:  Jeanelle Ariza; Hailee Rogers; Anna Hartvigsen; Melissa Snell; Michael Dill; Derek Judd; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Mov Disord       Date:  2017-02-24       Impact factor: 10.338

Review 8.  Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.

Authors:  Randi J Hagerman; Paul Hagerman
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

9.  Cerebellar Mild Iron Accumulation in a Subset of FMR1 Premutation Carriers with FXTAS.

Authors:  Hailee Rogers; Jeanelle Ariza; Angela Monterrubio; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

Review 10.  Update on the Clinical, Radiographic, and Neurobehavioral Manifestations in FXTAS and FMR1 Premutation Carriers.

Authors:  Deborah A Hall; Erin Robertson; Annie L Shelton; Molly C Losh; Montserrat Mila; Esther Granell Moreno; Beatriz Gomez-Anson; Verónica Martínez-Cerdeño; Jim Grigsby; Reymundo Lozano; Randi Hagerman; Lorena Santa Maria; Elizabeth Berry-Kravis; Joan A O'Keefe
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.